Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Mol Pharm. 2017 Mar 24;14(5):1646–1655. doi: 10.1021/acs.molpharmaceut.6b01123

Table 2.

Quantitative PET data of 64Cu-NOTA-heterodimer-ZW800 tracer uptakes after TF or CD105 blocking in BxPC-3-bearing nude mice

Blocking group Tissue Time post-injection of the tracer

3 h 12 h 24 h
TF blocking (n=3) BxPC-3 4.9 ± 1.5 5.2 ± 0.8 5.5 ± 1.1
Blood 11.0 ± 1.5 4.8 ± 0.6 3.4 ± 0.4
Liver 14.4 ± 1.5 12.0 ± 1.2 12.0 ± 1.6
Kidney 12.4 ± 1.5 13.0 ± 2.0 10.1 ± 0.8
Muscle 1.1 ± 0.1 1.0 ± 0.1 1.0 ± 0.2

CD105 blocking (n=3) BxPC-3 6.5 ± 2.7 10.5 ± 1.5 10.8 ± 0.7
Blood 10.9 ± 0.6 5.2 ± 0.5 4.4 ± 0.3
Liver 13.4 ± 1.9 11.5 ± 0.4 10.9 ± 0.9
Kidney 12.8 ± 0.6 13.1 ± 1.9 10.7 ± 0.5
Muscle 1.4 ± 0.2 1.0 ± 0.2 0.9 ± 0.2
*

Values are reported as %ID/g (mean ± SD)